CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award Chief Financial Officer acquired 3,101 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 4 Option exercise President and CEO acquired 20,500 shares (option exercise)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 1,158 shares (grant or award)
- 8-K Event Other events
- 4 Open-market sale President and CEO sold 36,000 shares at $15.00 ($540,000)
- 8-K Event Results of operations
Page 20 of 41 · 801 filings